PetMed Express insiders buy restricted shares, signaling CEO confidence and potential future growth—investors eye how this may lift the company’s value.
Investor insights on NINA Capital’s $1.75 share purchase of PetMed Express reveal insider confidence amid a 54% YTD decline, highlighting the potential for a retail‑pharmacy rebound and strategic digital expansion in the pet‑care sector.